[P29] Poster Session 29　Lung Cancer/Thoracic Cancer（ICI efficacy 1）

[P29-7] Therapeutic effects and prognostic factors of immune checkpoint inhibitors for NSCLC with oncogenic driver fusions

^○Hironori Satoh, Hidehito Horinouchi, Yuki Takeyasu, Masayuki Shirasawa, Ken Masuda, Yuki Shinno, Yuji Matsumoto, Yuske Ohkuma, Tastuya Yosida, Yasushi Goto, Noboru Yamamoto, Yuichiro Ohe (Department of Respiratory Medicine, Pulmonary Center, National Cancer Center Hospital, Tokyo, Japan)